These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33264039)

  • 1. Moonlighting in drug metabolism.
    Board PG; Anders MW
    Drug Metab Rev; 2021 Feb; 53(1):76-99. PubMed ID: 33264039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters.
    Atkins WM
    FEBS J; 2020 Apr; 287(7):1306-1322. PubMed ID: 31663687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mercapturic acid pathway.
    Hanna PE; Anders MW
    Crit Rev Toxicol; 2019 Nov; 49(10):819-929. PubMed ID: 31944156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II drug metabolizing enzymes.
    Jancova P; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Jun; 154(2):103-16. PubMed ID: 20668491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymes, pseudoenzymes, and moonlighting proteins: diversity of function in protein superfamilies.
    Jeffery CJ
    FEBS J; 2020 Oct; 287(19):4141-4149. PubMed ID: 32534477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.
    Fan PW; Zhang D; Halladay JS; Driscoll JP; Khojasteh SC
    Drug Metab Dispos; 2016 Aug; 44(8):1253-61. PubMed ID: 27117704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to protein moonlighting.
    Jeffery CJ
    Biochem Soc Trans; 2014 Dec; 42(6):1679-83. PubMed ID: 25399589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide.
    Atmane N; Dairou J; Paul A; Dupret JM; Rodrigues-Lima F
    J Biol Chem; 2003 Sep; 278(37):35086-92. PubMed ID: 12832400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moonlighting enzymes: when cellular context defines specificity.
    Gupta MN; Uversky VN
    Cell Mol Life Sci; 2023 Apr; 80(5):130. PubMed ID: 37093283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.
    Nishimura M; Naito S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):357-74. PubMed ID: 17072089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of enzymes of drug metabolism.
    Meyer UA
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes.
    Zöllner A; Buchheit D; Meyer MR; Maurer HH; Peters FT; Bureik M
    Bioanalysis; 2010 Jul; 2(7):1277-90. PubMed ID: 21083240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Investigation of 15 Xenobiotic-Metabolizing
    Garefalaki V; Papavergi MG; Savvidou O; Papanikolaou G; Felföldi T; Márialigeti K; Fakis G; Boukouvala S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0081921. PubMed ID: 34288706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical genetics and its application to moonlighting in glycolytic enzymes.
    Jung DW; Kim WH; Williams DR
    Biochem Soc Trans; 2014 Dec; 42(6):1756-61. PubMed ID: 25399602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Moonlighting Enzymes in Cancer.
    Lin C; Yu M; Wu X; Wang H; Wei M; Zhang L
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein moonlighting: what is it, and why is it important?
    Jeffery CJ
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.